March 01, 2018

Importing Prescription Drugs Remains Risky Business Due to FDA and DEA Regulation

Ronald Friedman, Esq., Karr Tuttle Campbell, Seattle, WA

Americans are living in a political climate where there is much concern about escalating retail drug prices and profits being earned by drug manufacturers in this country.1  This concern is accompanied by discussion of the often cheaper prices, by comparison, of equivalent prescription drugs in foreign countries.2  Repeated Congressional efforts to potentially address and remedy the issue have not been successful.3  This environment gives rise to potential inquiries of counsel by providers or individual patients in the United States seeking to avail themselves of such lower prices from foreign drug sources by importing such drugs.   This in turn raises questions of the legality of such importing.    

Premium Content For:
  • Health Law Section
Join - Now